Nanostructured Lipid Carriers with the Eichhornia crassipes Extract as a Receptor, ErB-2 Inhibitor in Breast Cancer: An in Silico Study

Authors

  • Jocelyn Thanur Santa Laurensia Senior High School South Tangerang Banten 15325, Indonesia
  • Alicia Carissa Hartanu Santa Laurensia Senior High School South Tangerang Banten 15325, Indonesia
  • Vonny Gandawiguna Santa Laurensia Senior High School South Tangerang Banten 15325, Indonesia

Keywords:

Eichhornia, Nanostructures, Lipids, Carrier, Receptor, ErB-2, Breast cancer, Molecular Docking Simulations

Abstract

In 2020, Indonesia had a total of 65.858 new breast cancer cases and the mortality rate reached 17 per 100,000 population in 2021. Human Epidermal Growth Factor Receptor 2 or Receptor, ErB-2 is a protein that is often used as a target for developing breast cancer drugs. Nowadays, an alternative drug from natural compounds has been developed to overcome the dangerous effect of the chemical drugs, for example by using Eichhornia extract. Due to its low solubility in water and bioavailability, it can be modified by a nanostructured lipid carrier as a sender. Therefore, this study aimed to determine the bioactive compounds in Eichhornia extract that can potentially act as Receptor, ErB-2 inhibitors when encapsulated in nanostructured lipid carriers. However, a nanostructured lipid carrier was constructed by encapsulating Eichhornia extract in vitro. According to the results of molecular docking simulations, luteolin, 2-hydroxy-8-(4 hydroxyphenyl)-phenalene-1-one, and 2-hydroxy-8-(3,4-dihydroxyphenyl)-phenalen-1-one have the highest bond energies and exceed the bond energy of the native ligand. The characterization test showed that the manufacturer’s nanostructured lipid carriers had an average size of 471.3 nm, a PDI of 0.507, a pH of 6.20, and a viscosity of 0.896 mPa·S. This nanostructured lipid carrier prototype has been successfully synthesized and nearly met the nanodrug characteristics. This present study could give a new insight in developing drug delivery that alleviate the harmful side effects of cancer chemotherapy.

Downloads

Download data is not yet available.

References

Gautama W (2022) Breast cancer in Indonesia in 2022: 30 years of marching in place. Indones J Cancer. 16:1-2. https://doi.org/10.33371/ijoc.v16i1.920.

Wang J, Xu B (2019) Targeted therapeutic options and future perspectives for HER2-positive breast cancer. Sig Transduct Target Ther. 4:34. https://doi.org/10.1038/s41392-019-0069-2.

Awada G, Gombos A, Aftimos P, Awada A (2016) Emerging drugs targeting human epidermal growth factor receptor 2 (HER2) in the treatment of breast cancer. Expert Opin Emerg Drugs. 21:91-101. https://doi.org/10.1517/14728214.2016.1146680.

Ratnani RD, Hartati I, Kurniasari L (2011) Pemanfaatan eceng gondok (Eichornia crassipes) untuk menurunkan kandungan COD (chemical oxygen demond), pH, bau, dan warna pada limbah cair tahu. Majalah Ilmiah Momentum. 7:41-47. https://dx.doi.org/10.36499/jim.v7i1.296.

Coimbra M, Isacchi B, van Bloois L, Torano JS, Ket A, Wu X, Broere F, Metselaar JM, Rijcken CJ, Storm G, Bilia R, Schiffelers RM (2011) Improving solubility and chemical stability of natural compounds for medicinal use by incorporation into liposomes. Int J Pharm. 416:433-442. https://doi.org/10.1016/j.ijpharm.2011.01.056.

Singhvi G, Banerjee S, Khosa A (2018) Lyotropic liquid crystal nanoparticles. In: Grumezescu AM eds. Organic materials as smart nanocarriers for drug delivery. New York: William Andrew. 471-517. https://doi.org/10.1016/b978-0-12-813663-8.00011-7.

Chauhan I, Yasir M, Verma M, Singh AP (2020) Nanostructured lipid carriers: A groundbreaking approach for transdermal drug delivery. Adv Pharm Bull. 10:150-165. https://doi.org/10.34172/apb.2020.021.

Rohmah M, Raharjo S, Hidayat C, Martien R (2019) Formulation and stability of nanostructured lipid carrier from a mixture of palm stearin and palm olein. J Aplikasi Teknologi Pangan. 8:23-30.

Yang SC, Chang SS, Chen CY (2011) Identifying HER2 inhibitors from natural products database. PLoS One. 6:e28793. https://doi.org/10.1371/journal.pone.0028793.

Yang YD, Corona A, Bhatia SR, Henson MA (2015) The controlled aggregation and tunable viscosity of nanostructured lipid carrier dispersions. Colloids Surf A: Physicochem Eng Asp. 482:138-147. https://doi.org/10.1016/j.colsurfa.2015.04.036.

Danaei M, Dehghankhold M, Ataei S, Hasanzadeh Davarani F, Javanmard R, Dokhani A, Khorasani S, Mozafari MR (2018) Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems. Pharmaceutics. 10:57. https://doi.org/10.3390/pharmaceutics10020057.

Downloads

Published

2024-06-01

How to Cite

Jocelyn Thanur, Alicia Carissa Hartanu and Gandawiguna, V. (2024) “Nanostructured Lipid Carriers with the Eichhornia crassipes Extract as a Receptor, ErB-2 Inhibitor in Breast Cancer: An in Silico Study”, Bioinformatics and Biomedical Research Journal, 7(1), pp. 1–20. Available at: https://bbrjournal.com/index.php/bbrj/article/view/157 (Accessed: 11 February 2025).